Biology ETDs
Publication Date
Spring 4-15-2018
Abstract
Malaria has had an unspeakable toll on human economy and wellbeing. Every year, there are approximately 212 million malaria infections caused by Plasmodium falciparum leading to 429,000 deaths, the vast majority of which occur in sub-Saharan Africa where the parasite is endemic. Decades of widespread use, and probable misuse, of antimalarial drugs has created extraordinary selective pressure on the parasite and made many formerly effective drugs ineffective. Currently, artemisinin and artemisinin derivatives are the most effective treatment available but resistance to dihydroartemisinin (DHA), the active ingredient, is emerging. Continued monitoring for genetic mutations linked with resistance is vital to global health. My project tested for the prevalence of artemisinin resistant SNPs using a simple and inexpensive TaqMan Assay™. Of the five SNPs examined, I found evidence of only one mutant, the Y630F SNP, within the pfkelch13 gene. Though this information is valuable, there were limitations to the study. Samples should be genotyped to identify other mutations and monoclonal vs. polyclonal infections. Samples collected at other time points, particularly prior to 2006, should also be run.
Language
English
Keywords
Malaria, single nucleotide polymorphisms, artemisinin, resistance
Document Type
Thesis
Degree Name
Biology
Level of Degree
Masters
Department Name
UNM Biology Department
First Committee Member (Chair)
Dr. Eric Toolson
Second Committee Member
Dr. Douglas Perkins
Third Committee Member
Dr. Dorothy Scholl
Recommended Citation
Glenn, Elizabeth M.. "Prevalence of Artemisinin Resistance Associated Single Nucleotide Polymorphisms in Kenyan Isolates." (2018). https://digitalrepository.unm.edu/biol_etds/262